ArticleBMC nephrology2026
Kidney biopsy during pregnancy or wait postpartum: two decades experience from a single center.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney biopsy is the gold standard for diagnosing kidney disease, yet its use during pregnancy remains controversial due to concerns about procedure related complications and limited contemporary evidence. This study evaluates long term kidney outcomes with biopsy timing in pregnant and postpartum females.
methodsWe conducted a retrospective cohort study spanning over 22-years including females aged ≥ 18 years who underwent native kidney biopsy during pregnancy or within three months postpartum. Demographic, clinical, histopathological, maternal, fetal, and long-term kidney outcomes were abstracted from electronic health records. Kaplan-Meier analysis evaluated kidney survival, defined as time to dialysis initiation and statistical significance was set at p-value < 0.05.
resultsIn our cohort, 29 females met inclusion criteria: 13 biopsied during pregnancy and 16 postpartum. Long term kidney survival did not differ significantly between groups (log rank p = 0.3). Complication rates were comparable between groups; low, limited to small, and self-limiting hematomas. Lupus nephritis was the most frequent diagnosis in both groups. DISCUSSION: Although long term dialysis rates were comparable between the two groups, the postpartum cohort had a shorter duration of follow up. Biopsies performed during pregnancy and postpartum were safe in this cohort and yielded clinically meaningful information that frequently altered acute management. Nephrotic range proteinuria and an eGFR below 60 mL/min/1.73 m² were key predictors of progression to ESKD.
conclusionIn our study, no statistically significant difference in long-term kidney survival was observed by biopsy timing during pregnancy vs. postpartum, even though pregnancy group had much longer follow-up than the postpartum group.
Indexed as
Identifiers
42477653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.